Companies: 10,795·Total market cap: $144.5T
Cerecor Inc.

Cerecor Inc.

CERCNASDAQHealthcare
$2.93
$-0.05(-1.68%)
Market Cap$38629413
P/E Ratio
52W High$2.98
52W Low$2.9
Overview

Cerecor Inc. (CERC) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

cerc · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Cerecor Inc. (CERC) measures how much investors pay for each dollar of the company's trailing earnings. CERC's current PE ratio of N/A is calculated by dividing its stock price of $2.93 by its TTM earnings per share of -$4.87.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
EPS (TTM)
-$4.87
TTM · diluted EPS
PEG Ratio
0.01
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cerecor Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2024 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Cerecor Inc.
Cerecor Inc.You
CERC
$39MN/A-$4.87
Grace Therapeutics, Inc.
Grace Therapeutics, Inc.
GRCE
$37MN/A-$1.13
Opus Genetics, Inc.
Opus Genetics, Inc.
IRD
$330MN/A-$0.08
LianBio
LianBio
LIANY
$12M2.11x$0.05
Lumos Pharma, Inc.
Lumos Pharma, Inc.
LUMO
$38MN/A-$4.18
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc.
MGTA
$42MN/A$0.00
Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc.
ORKA
$2.5BN/A-$2.31

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 2 of 2 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-5.84
2024-12-31
FY2024
$-3.34

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Cerecor Inc. (CERC) measures how much investors pay for each dollar of the company's trailing earnings. CERC's current PE ratio of N/A is calculated by dividing its stock price of $2.93 by its TTM earnings per share of -$4.87.

PE Ratio = Stock Price ÷ EPS (TTM)
= $2.93 ÷ -$4.87 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CERC pe ratio · 6 questions

CERC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.93 and TTM EPS of -$4.87. Data sourced from Financial Modeling Prep via CERC's SEC 10-K and 10-Q filings.

CERC PE ratioWhat is CERC PE ratioCurrent PE ratio of CERCCERC PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cerecor Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09